Top Story

Shared medical appointments can be successful prior to Mohs micrographic surgery

December 15, 2014

Patients preparing to undergo Mohs micrographic surgery reported a high level of satisfaction after attending shared medical appointments, according to recently published study results.

“Shared medical appointments (SMAs) allow patients with similar diagnoses to be simultaneously educated and cared for by one provider,” the researchers wrote. “SMAs appear well-suited for Mohs micrographic surgery because all patients received similar information about skin cancer pathophysiology, prognosis, prevention, treatment, reconstructive options and wound care.”

Amgen initiates study to evaluate combined talimogene laherparepvec, Keytruda for melanoma

December 10, 2014
Amgen announced the beginning of a study to evaluate the safety and efficacy of talimogene laherparepvec in combination with the investigational use of Merck’s…
Jerry D. Brewer, MD In the Journals

Patients with non-Hodgkin lymphoma had high recurrence of nonmelanoma skin cancer

December 9, 2014
Patients with non-Hodgkin lymphoma experienced high recurrence rates of basal cell carcinoma and squamous cell carcinoma following Mohs micrographic surgery, according…

Celldex begins phase 2 study of glembatumumab vedotin for advanced melanoma

December 8, 2014
Celldex Therapeutics has begun an open-label phase 2 study of glembatumumab vedotin for treating patients with unresectable stage III or IV melanoma, according to a…
CME
PD-1 Antibodies

PD-1 Antibodies

This activity is supported by educational grants from Bristol-Myers Squibb, Delcath Systems, Inc., Merck & Co., Inc., OncoSec Medical, Inc., Prometheus and Provectus Pharmaceuticals, Inc.

This activity will review data on the efficacy, safety, and response patterns observed with PD-1 in patients with…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
In the Journals

Shared medical appointments can be successful prior to Mohs micrographic surgery

December 15, 2014
Patients preparing to undergo Mohs micrographic surgery reported a high level of satisfaction after attending shared medical appointments, according…

Amgen initiates study to evaluate combined talimogene laherparepvec, Keytruda for melanoma

December 10, 2014
Amgen announced the beginning of a study to evaluate the safety and efficacy of talimogene laherparepvec in combination with the investigational use…
Jerry D. Brewer, MD In the Journals

Patients with non-Hodgkin lymphoma had high recurrence of nonmelanoma skin cancer

December 9, 2014
Patients with non-Hodgkin lymphoma experienced high recurrence rates of basal cell carcinoma and squamous cell carcinoma following Mohs micrographic…

Celldex begins phase 2 study of glembatumumab vedotin for advanced melanoma

December 8, 2014
Celldex Therapeutics has begun an open-label phase 2 study of glembatumumab vedotin for treating patients with unresectable stage III or IV melanoma…
In the Journals

SLNB did not improve survival in head and neck melanoma

December 4, 2014
Patients with head and neck melanoma who underwent sentinel lymph node biopsy derived no disease-specific survival benefit compared with patients who…
In the Journals

Frequency of TERT promoter mutations in cutaneous melanoma varied by subtype

December 2, 2014
TERT promoter mutations are one of the most common genetic alterations in cutaneous melanoma, and their frequency varied considerably depending on…
In the Journals

Total-body photography may reduce melanoma worry in patients with atypical mole syndrome

November 26, 2014
The use of total-body digital photography may reduce concerns about melanoma development among patients with atypical mole syndrome, according to…
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites…
In the Journals

Melanoma tumor genetics determined clinical benefit from CTLA-4 blockades

November 20, 2014
The presence of somatic neo-epitopes was associated with prolonged clinical benefit from CTLA-4 blockades in patients with melanoma, according to…
Dabrafenib–trametinib combination extended survival in metastatic melanoma In the Journals

Dabrafenib–trametinib combination extended survival in metastatic melanoma

November 17, 2014
The combination of dabrafenib and trametinib significantly extended OS compared with vemurafenib monotherapy in patients with treatment-naive…
More Headlines »